Get the content you want anytime you want.

Select coverage from The Annual Conference on Retroviruses and Opportunistic Infections (CROI) is included below:

Dolutegravir with Darunavir/Cobicistat Safe to Prescribe in Treatment of HIV, Study Suggests
A new study suggests that an antiretroviral combination of dolutegravir with darunavir/cobicistat can be prescribed safely in the treatment of HIV-1.
Improving Access to Patient Care & Time to Viral Suppression Using HIV Rapid Entry Programs
Implementation of a rapid entry program decreased time to first provider appointment, time to initiation of ART, and time to viral suppression in the Southern United States.
D/C/F/TAF Achieves High Virologic Response Rates Consistent Across Age, Gender, & Race Subgroups in ART-Naive HIV Patients
D/C/F/TAF achieved high virologic response rates that were overall noninferior to the control D/C+F/TDF, as well as favorable bone and renal outcomes that were consistent across age, gender, and race subgroups in phase 3 AMBER trial.
New Single-Tablet HIV Treatment Regimen Performs Well in Treatment-Experienced Patients Across All Race, Gender, and Age Groups
Posthoc analysis of the EMERALD trial reveal the combination regimen of D/C/F/TAF performs well in HIV-positive patients across different race, gender, and age subgroups, who may have failed previous antiviral regimens. 
Top Infectious Disease News of the Week—March 11, 2018
In case you missed them, we've compiled the top five infectious disease articles from this past week.
Antiretroviral Agent Expected to Suppress HIV After Multiple Daily Doses as Low as 0.25 mg
All doses of MK-8591 were generally well-tolerated with a limited number of reported mild/moderate adverse events.
Risk of Female HIV Acquisition Per Sex Act Increases During Pregnancy
Recent research presented at CROI 2018 finds that the risk of female HIV acquisition per sex act steadily increased through pregnancy and was highest during postpartum.
Doxycycline Looks to Be Acceptable Alternate Treatment for Syphilis in HIV-Positive Patients
Recent research presented at CROI reveals that doxycycline is an acceptable treatment alternative for HIV-positive patients who are infected with syphilis.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.